Certificate-of-need in an antitrust context
Journal of Health Politics, Policy and Law
|January 1, 1983
Summary
Certificate-of-need (CON) laws do not eliminate antitrust scrutiny. Provider input in CON processes may be protected by state action and Noerr-Pennington doctrines, but must aid decision-making, not just serve provider interests.
Area of Science:
- Healthcare Law
- Antitrust Law
- Health Policy
Background:
- Certificate-of-need (CON) legislation aims to control healthcare costs and access.
- Recent legal cases indicate CON laws do not inherently grant antitrust immunity.
- The intersection of healthcare regulation and antitrust law is a complex area.
Purpose of the Study:
- To analyze the extent to which antitrust considerations are preserved under CON legislation.
- To examine the applicability of the state action doctrine and Noerr-Pennington doctrine to CON processes.
- To differentiate between legitimate information provision and self-serving data in CON proceedings.
Main Methods:
- Legal analysis of recent case law, specifically National Gerimedical Hospital v. Blue Cross of Kansas City.
- Discussion of relevant antitrust exemptions: state action doctrine (Parker v. Brown) and Noerr-Pennington doctrine.
- Examination of the nature of provider input within the CON framework.
Main Results:
- CON legislation does not automatically exempt healthcare providers from antitrust laws.
- The state action and Noerr-Pennington doctrines may shield certain provider activities within the CON process.
- A critical distinction exists between information that genuinely assists regulatory decision-making and information that primarily benefits providers.
Conclusions:
- Antitrust principles remain relevant in the context of CON regulation.
- Healthcare providers' influence on CON decisions is subject to specific legal doctrines and scrutiny.
- Careful evaluation is needed to ensure provider input serves public health goals rather than private interests.
Related Concept Videos
01:08Obedience
According to obedience research, we may harm others under the forceful pressures of an authority figure (Milgram, 1974). How about if the inappropriate orders were delivered with less force? The increasing interdependence between nurses and physicians compelled Hofling and his colleagues to explore nurses’ reactions to a potentially harmful medical request made by the perceived authority figure, the doctor (Hofling, Brotzman, Dalrymple, Graves, & Pierce, 1966). In this situation, obedience...
01:30National Nursing Organizations II
Nursing organizations play a vital role in representing nurses working in specialized clinical settings, such as the American Association of Critical-Care Nurses (AACN).
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
01:22Standards of Care I
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...